The mammalian target of rapamycin (mTOR) regulates basic cellular processes, including protein synthesis and cell proliferation, growth, and metabolism, which plays a critical role in the progression of breast cancer [3,4,5,6]. This evidence concerns the gene MTOR and breast cancer.